Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update

The coronavirus disease 2019 (COVID-19) pandemic has revolutionized the priorities of the medical society worldwide. Although most patients infected with SARS-CoV-2 exhibit respiratory symptoms, other organs may also be involved, including the liver, often resulting in liver injury. Non-alcoholic fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Miranda, Cesare, Garlatti, Elena, Da Porto, Andrea, Rinaldo, Elena, Grazioli, Silvia, Zanette, Giorgio, Tonizzo, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
State of the Art Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161789/
https://www.ncbi.nlm.nih.gov/pubmed/37153375
http://dx.doi.org/10.5114/amsad/160950
_version_ 1785037565136470016
author Miranda, Cesare
Garlatti, Elena
Da Porto, Andrea
Rinaldo, Elena
Grazioli, Silvia
Zanette, Giorgio
Tonizzo, Maurizio
author_facet Miranda, Cesare
Garlatti, Elena
Da Porto, Andrea
Rinaldo, Elena
Grazioli, Silvia
Zanette, Giorgio
Tonizzo, Maurizio
author_sort Miranda, Cesare
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic has revolutionized the priorities of the medical society worldwide. Although most patients infected with SARS-CoV-2 exhibit respiratory symptoms, other organs may also be involved, including the liver, often resulting in liver injury. Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and its prevalence is expected to increase together with the epidemics of type 2 diabetes and obesity. Data about liver injury during COVID-19 are numerous, while overviews of this infection in patients with NAFLD, both in terms of respiratory and liver, are emerging. In this review, we summarise the current research focusing on COVID-19 in NAFLD patients and discuss the association between liver injury in COVID-19 subjects and non-alcoholic fatty liver disease.
format Online
Article
Text
id pubmed-10161789
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-101617892023-05-06 Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update Miranda, Cesare Garlatti, Elena Da Porto, Andrea Rinaldo, Elena Grazioli, Silvia Zanette, Giorgio Tonizzo, Maurizio Arch Med Sci Atheroscler Dis State of the Art Paper The coronavirus disease 2019 (COVID-19) pandemic has revolutionized the priorities of the medical society worldwide. Although most patients infected with SARS-CoV-2 exhibit respiratory symptoms, other organs may also be involved, including the liver, often resulting in liver injury. Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and its prevalence is expected to increase together with the epidemics of type 2 diabetes and obesity. Data about liver injury during COVID-19 are numerous, while overviews of this infection in patients with NAFLD, both in terms of respiratory and liver, are emerging. In this review, we summarise the current research focusing on COVID-19 in NAFLD patients and discuss the association between liver injury in COVID-19 subjects and non-alcoholic fatty liver disease. Termedia Publishing House 2023-02-23 /pmc/articles/PMC10161789/ /pubmed/37153375 http://dx.doi.org/10.5114/amsad/160950 Text en Copyright: © 2023 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle State of the Art Paper
Miranda, Cesare
Garlatti, Elena
Da Porto, Andrea
Rinaldo, Elena
Grazioli, Silvia
Zanette, Giorgio
Tonizzo, Maurizio
Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update
title Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update
title_full Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update
title_fullStr Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update
title_full_unstemmed Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update
title_short Liver injury in COVID-19 patients with non-alcoholic fatty liver disease: an update
title_sort liver injury in covid-19 patients with non-alcoholic fatty liver disease: an update
topic State of the Art Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161789/
https://www.ncbi.nlm.nih.gov/pubmed/37153375
http://dx.doi.org/10.5114/amsad/160950
work_keys_str_mv AT mirandacesare liverinjuryincovid19patientswithnonalcoholicfattyliverdiseaseanupdate
AT garlattielena liverinjuryincovid19patientswithnonalcoholicfattyliverdiseaseanupdate
AT daportoandrea liverinjuryincovid19patientswithnonalcoholicfattyliverdiseaseanupdate
AT rinaldoelena liverinjuryincovid19patientswithnonalcoholicfattyliverdiseaseanupdate
AT graziolisilvia liverinjuryincovid19patientswithnonalcoholicfattyliverdiseaseanupdate
AT zanettegiorgio liverinjuryincovid19patientswithnonalcoholicfattyliverdiseaseanupdate
AT tonizzomaurizio liverinjuryincovid19patientswithnonalcoholicfattyliverdiseaseanupdate

Ejemplares similares